Trial Profile
A DOUBLE BLIND, RANDOMISED, PARALLEL, PLACEBO-CONTROLLED, PILOT STUDY TO EVALUATE THE ANTI-INFLAMMATORY EFFECTS AND THE EFFICACY OF RUPATADINE 10 MG ON THE SYMPTOMS OF PERSISTENT ALLERGIC RHINITIS.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jun 2011
Price :
$35
*
At a glance
- Drugs Rupatadine (Primary)
- Indications Allergic rhinitis
- Focus Therapeutic Use
- Sponsors Uriach
- 14 Jun 2011 New trial record